Optimizing Implementation of Long Acting Injectable PrEP
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 20
- 主要终点
- LAI-PrEP prescribing
研究概览
简要总结
Our goal is to optimize LAI-PrEP implementation within the context of other PrEP methods. Our strategy is flexible to allow pivot to include forthcoming PrEP dosing options should they become available
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Provider/staff inclusion criteria:
- •18 years of age or older,
- •affiliated with a participating clinic, and
- •be involved in prescribing or supporting PrEP care delivery.
- •Provider/staff
排除标准
- •17 years of age or younger,
- •not affiliated with a participating clinic, and
- •not involved in prescribing or supporting PrEP care delivery.
- •De-identified electronic medical record review inclusion criteria:
- •16 years of age or older, and
- •had a clinical visit for any form of PrEP care during the study period at a participating clinic site.
- •De-identified electronic medical record review exclusion criteria:
- •15 years of age or younger, and
- •no clinical visit for any form of PrEP care during the study period at a participating clinic site.
研究组 & 干预措施
Control
Observational control period
Clinic Implementation
We will implement changes responsive to current obstacles to LAI-PrEP care delivery with serial systematic evaluation. Preliminary impact of LAI-PrEP implementation will be evaluated using RE-AIM, assessing Reach, Effectiveness, Adoption, Implementation, and Maintenance via electronic medical records review, survey, and exit interviews. Exit interviews will also determine feasibility, acceptability, and appropriateness of Plan-Do-Study-Act as a clinic-based implementation strategy.
干预措施: Plan-Do-Study-Act (Behavioral)
结局指标
主要结局
LAI-PrEP prescribing
时间窗: 3 months
Proportion of eligible patients prescribed LAI-PrEP
次要结局
未报告次要终点